Encyclopedia of Signaling Molecules

2012 Edition
| Editors: Sangdun Choi

p38 MAPK Family of Signal Transduction Proteins

  • John Papaconstantinou
  • Ching-Chyuan Hsieh
  • James H. DeFord
Reference work entry
DOI: https://doi.org/10.1007/978-1-4419-0461-4_221


Historical Background: The p38 MAPK Family of Stress Response Signaling

The biological transduction of physiological and environmental signals involves highly specific protein–protein interactions and posttranslational modifications that regulate both genetic and epigenetic processes in response to intrinsic and extrinsic challenges. The overall biochemical phenotype of tissues at all stages of the life cycle, i.e., growth and development,...
This is a preview of subscription content, log in to check access.


  1. Ben-Levy R, Hooper S, Wilson R, Paterson HF, Marshall CJ. Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2. Curr Biol. 1998;8:1049–57.PubMedGoogle Scholar
  2. Cardier JE, Erickson-Miller CL. Fas (CD95)-and tumor necrosis factor mediated apoptosis in liver endothelial cells; role of caspase-3 and the p38 MAPK. Microvasc Res. 2002;63:10–8.PubMedGoogle Scholar
  3. Conrad PW, Rust RT, Han J, Milkorn DE, Beitner-Johnson D. Selective activation of p38α and p38β by anoxia. Role in regulation of cyclin D1 by hypoxia in PC12 cells. J Biol Chem. 1999;274:23570–6.PubMedGoogle Scholar
  4. Cuadrado A, Nebreda AR. Mechanism and functions of p38 MAPK signaling. Biochem J. 2010;429:403–17.PubMedGoogle Scholar
  5. Engel K, Schultz H, Martin F, Kotlyarov A, Plath K, Hahn M, et al. Constitutive activation of mitogen-activated protein kinase 2 by mutation of phosphorylation sites and an A-helix motif. J Biol Chem. 1995;270:27213–21.PubMedGoogle Scholar
  6. Enslen H, Raingeaud J, Davis RJ. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J Biol Chem. 1998;273:1741–8.PubMedGoogle Scholar
  7. Gavin AC, Nebreda AR. A MAP kinase docking site is required for phosphorylation and activation of p90(rsk)/MAPKP kinase-1. Curr Biol. 1999;11:281–4.Google Scholar
  8. Haq R, Brenton JD, Takahashi M, Finan D, Finkelsztein A, Damaraju S, Rotapel R, Zanke B. Constitutive p38HOG mitogen-activated protein kinase activation induces permanent cell cycle arrest and senescence. Cancer Res. 2002;62:5076–82.PubMedGoogle Scholar
  9. Hutter D, Chen P, Barnes J, Liu Y. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation. Biochemistry. 2000;352:155–63.Google Scholar
  10. Jiang Y, Gram H, Zhao M, New L, Gu J, Feng L, Padova F, Ulevitch R, Han J. Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38δ. J Biol Chem. 1997;333:30122–8.Google Scholar
  11. Keyse SM. Protein phosphatases and the regulation of mitogen-activated protein kinase signaling. Curr Opin Cell Biol. 2000;12:186–92.PubMedGoogle Scholar
  12. Kim DH, Feinbaum R, Alloing G, Emerson FE, Garsin DA, Inoue H, Tanaka-Hino M, Hisamoto N, Matsumoto K, Tan V-W, Ausubel FM. A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity. Science. 2002;297:623–6.PubMedGoogle Scholar
  13. Lechner C, Zahalka MA, Giot F-F, Moler NPH, Ullrich A. ERK6, a mitogen-activated protein kinase involved in G2C12 myoblast differentiation. Proc Natl Acad Sci USA. 1996;93:4355–9.PubMedGoogle Scholar
  14. Lee JC, Kassis S, Kumar S, Badger A, Adams JL. p38-mitogen activated protein kinase inhibitors—mechanisms and therapeutic potentials. Pharmacol Ther. 1999;82:389–97.PubMedGoogle Scholar
  15. Li Z, Jiang Y, Ulevitch RJ, Han J. The primary structure of p38gamma: a new member of p38 group of MAP kinases. Biochem Biophys Res Commun. 1996;228:334–40.PubMedGoogle Scholar
  16. Muda M, Theodosiou A, Gillieron C, Smith A, Chabert C, Camps M, Boschert U, Rodrigues N, Davies K, Ashworth A, Arkinstall S. The mitogen-activated protein kinase phosphatase-3 N-terminal noncatalytic region is responsible for tight substrate binding and enzymatic specificity. J Biol Chem. 1998;273:9323–9.PubMedGoogle Scholar
  17. Ono K, Han J. The p38 signal pathway activation and function. Cell Signal. 2000;12:1–13.PubMedGoogle Scholar
  18. Papaconstantinou J, Hsieh C-C. Activation of senescence and aging characteristics by mitochondrially generated Ros: how are they linked? Cell Cycle. 2010;9:1–3.Google Scholar
  19. Park JM, Greten FR, Li ZW, Karin M. Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science. 2002;297:2048–51.PubMedGoogle Scholar
  20. Peifer C, Abadleh M, Bischof J, Hauser D, Schattel V, Hirner H, Knippschild U, Laufer S. 3,4-diaryl-isoxazoles and –imidazoles as potent dual inhibitors of p38α mitogen activated protein kinase and casein kinase 1δ. J Med Chem. 2009;52:7618–730.PubMedGoogle Scholar
  21. Saurin AT, Martin JL, Heads RJ, Foley C, Mockridge JW, Wright MJ, Wang Y, Marber MS. The role of differential activation of p38-mitogen-activated protein kinase in preconditioned ventricular myocytes. FASEB J. 2000;14:2237–46.PubMedGoogle Scholar
  22. Suh Y. Age-specific changes in expression, activity, and activation of the c-Jun NH(2)-terminal kinase and p38 mitogen-activated protein kinases by methyl methanesulfonate in rats. Mech Age Dev. 2001;122:1797–811.Google Scholar
  23. Tanoue T, Ryota M, Adachi M, Nichida E. Identification of docking groove on ERK and p38 MAP kinases that regulate the specificity of docking interactions. EMBO J. 2001;20:466–79.PubMedGoogle Scholar
  24. Wang YU, Huang S, Sah VP, Ross Jr J, Brown JH, Han J, Chien KR. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem. 1998;273:2161–8.PubMedGoogle Scholar
  25. Yang SH, Whitemarsh AJ, Davis RJ, Sharrocks AD. Differential targeting of MAP kinases to the ETS-domain transcription factor E1k-1. EMBO J. 1998;17:1740–9.PubMedGoogle Scholar
  26. Yang SH, Galanis A, Sharrocks AD. 1999 Targeting of p38 mitogen-activated protein kinase to MEF2 transcription factors. Mol Cell Biol. 1999;19:4028–38.PubMedGoogle Scholar
  27. Zer C, Sachs G, Shin JM. Identification of genomic targets downstream of p38 mitogen-activated protein kinase pathway mediating tumor necrosis factor-α signaling. Physiol Genomics. 2007;31:343–51.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • John Papaconstantinou
    • 1
    • 2
  • Ching-Chyuan Hsieh
    • 1
  • James H. DeFord
    • 1
  1. 1.Department of Biochemistry and Molecular BiologyUniversity of Texas Medical BranchGalvestonUSA
  2. 2.Department of Human Biological Chemistry and GeneticsThe University of Texas Medical BranchGalvestonUSA